Results 251 to 260 of about 25,190 (292)
Some of the next articles are maybe not open access.
Therapeutic Drug Monitoring, 2019
Hemophilia A and B are hereditary bleeding disorders, caused by a deficiency of clotting factor VIII or clotting factor IX, respectively. To treat and prevent bleedings, patients can administer clotting factor concentrates (hemophilia A and B) or ...
T. Preijers +6 more
semanticscholar +1 more source
Hemophilia A and B are hereditary bleeding disorders, caused by a deficiency of clotting factor VIII or clotting factor IX, respectively. To treat and prevent bleedings, patients can administer clotting factor concentrates (hemophilia A and B) or ...
T. Preijers +6 more
semanticscholar +1 more source
Neurourology and Urodynamics, 2019
To systematically assess all available evidence on efficacy and safety of desmopressin for treating nocturia in patients with multiple sclerosis (MS).
V. Phé +7 more
semanticscholar +1 more source
To systematically assess all available evidence on efficacy and safety of desmopressin for treating nocturia in patients with multiple sclerosis (MS).
V. Phé +7 more
semanticscholar +1 more source
Desmopressin (DDAVP) and hemostasis
Annals of Hematology, 1994Desmopressin is a widely used hemostatic drug. It is a synthetic analogue of the natural hormone vasopressin, but, in contrast to vasopressin, it has no pressor activity. The effect is immediate, with two- to sixfold increases in the plasma concentrations of coagulation factor VIII, on Willebrand factor, and tissue plasminogen activator, and increases ...
openaire +3 more sources
Desmopressin in Nocturnal Enuresis
Journal of Urology, 1991The effect of intranasal desmopressin on primary nocturnal enuresis was investigated in a study divided into 2 parts in which the first part was a randomized, double-blind, placebo-controlled cross-over study of 52 Finnish school children 5 to 13 years old.
openaire +3 more sources
Severe hyponatremia due to desmopressin
The Journal of Emergency Medicine, 2006Nasal desmopressin (DDAVP) is a commonly prescribed antidiuretic hormone (ADH) analogue used for treatment of diabetes insipidus, polyuria and nocturnal enuresis. Although it is generally well tolerated, it can cause severe electrolyte imbalance. Numerous reports exist on cases of mild to moderate DDAVP-induced hyponatremia, yet few reports describe ...
Sean O. Henderson, H. Brendan Kelleher
openaire +2 more sources
2001
Noniatrogenic Cushing’s syndrome is a rare clinical entity that is caused by an inappropriately elevated endogenous cortisol production and results in significant morbidity and mortality in affected patients. Despite its rarity, Cushing’s syndrome represents one of the most challenging diseases in clinical endocrinology because, despite the use of a ...
S. Tsagarakis, N. Thalassinos
openaire +2 more sources
Noniatrogenic Cushing’s syndrome is a rare clinical entity that is caused by an inappropriately elevated endogenous cortisol production and results in significant morbidity and mortality in affected patients. Despite its rarity, Cushing’s syndrome represents one of the most challenging diseases in clinical endocrinology because, despite the use of a ...
S. Tsagarakis, N. Thalassinos
openaire +2 more sources
Journal of Pediatric Urology
Desmopressin is well accepted as first-line medical therapy for enuresis. If ineffective, combination therapy of desmopressin + oxybutynin or desmopressin + imipramine has been used. This study assessed the efficacy of adjunct therapy with either imipramine or oxybutynin in the management of enuresis patients who failed desmopressin treatment.A ...
Spencer Shain +12 more
openaire +2 more sources
Desmopressin is well accepted as first-line medical therapy for enuresis. If ineffective, combination therapy of desmopressin + oxybutynin or desmopressin + imipramine has been used. This study assessed the efficacy of adjunct therapy with either imipramine or oxybutynin in the management of enuresis patients who failed desmopressin treatment.A ...
Spencer Shain +12 more
openaire +2 more sources
Desmopressin for the treatment of haemophilia
Haemophilia, 2007Summary. The synthetic vasopressin analogue (1–deamino‐8‐d‐arginine‐vasopressin) increases plasma concentration of factor VIII and von Willebrand factor in normal subjects and patients with mild haemophilia A and von Willebrand disease. Since its first clinical use in 1977, desmopressin has become the treatment of choice for patients with haemophilia ...
openaire +3 more sources
Desmopressin for nocturia in adults
Drug and Therapeutics Bulletin, 2017Desmopressin has been used for many years in the treatment of diabetes insipidus, nocturnal enuresis (involuntary urination while asleep) and nocturia associated with multiple sclerosis (in adults aged up to 65 years); it has also been recommended in certain circumstances for the treatment of nocturia in men and women (previously, an unlicensed use).1 ...
openaire +2 more sources